[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Page 55504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22129]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Registration, 
Noramco, Inc., (GA)

    By Notice dated May 9, 2012, and published in the Federal Register 
on May 21, 2012, 77 FR 30026, Noramco, Inc., 1440 Olympic Drive, 
Athens, Georgia 30601, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of 
controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Noramco, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substance listed.

     Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-22129 Filed 9-7-12; 8:45 am]
BILLING CODE 4410-09-P